Jamaicamide A

Last updated
Jamaicamide A
JAMAICAMIDE A.png
Names
Preferred IUPAC name
(E,9E)-14-bromo-9-(chloromethylidene)-N-[(E)-3-methoxy-5-(2-methyl-5-oxo-2H-pyrrol-1-yl)-5-oxopent-3-enyl]-6-methyltetradec-4-en-13-ynamide
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
KEGG
PubChem CID
  • Key: NAIKIJSSBJHCBL-IPUGVWFUSA-N
  • InChI=1S/C27H36BrClN2O4/c1-21(12-14-23(20-29)10-5-4-8-17-28)9-6-7-11-25(32)30-18-16-24(35-3)19-27(34)31-22(2)13-15-26(31)33/h6,9,13,15,19-22H,4-5,7,10-12,14,16,18H2,1-3H3,(H,30,32)/b9-6+,23-20+,24-19+
  • CC1C=CC(=O)N1C(=O)C=C(CCNC(=O)CCC=CC(C)CCC(=CCl)CCCC#CBr)OC
  • CC1C=CC(=O)N1C(=O)/C=C(\CCNC(=O)CC/C=C/C(C)CC/C(=C/Cl)/CCCC#CBr)/OC
Properties
C27H36BrClNO4
Molar mass 553.94 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

Jamaicamide A is a lipopeptide isolated from the cyanobacterium Moorea producens , formerly known as Lyngbya majuscula . [1] Jamaicamide A belongs to a family of compounds collectively called jamaicamides, which are sodium channel blockers with potent neurotoxicity in a cellular model. Jamaicamide A has several unusual functionalities, including an alkynyl bromide, vinyl chloride, β-methoxy eneone system, and pyrrolinone ring. [2]

Contents

History

Jamaicamide A was discovered by William H. Gerwick from Oregon State University, Corvallis, Oregon, USA. This natural product was isolated from a dark green strain of Moorea producens , formerly known as Lyngbya majuscula , marine cyanobacteria collected from Hector Bay, Jamaica. The initial small amount of crude extract has shown potent brine shrimp toxicity. The organism was cultured in the laboratory, producing ten g/l of biomass after six weeks. The compound was extracted using standard methods for lipid natural products, and the fractionation process was performed using vacuum liquid chromatography (VLC). [2]

Jamaicamide A exhibited moderate in vitro cytotoxicity to H-460 human lung and Neuro-2a mouse neuroblastoma cell lines with an IC50 value of 15 μM for both cell lines. This compound also displayed low micromolar inhibition of sodium channel-blocking activity at 5 μM. In a goldfish toxicity assay, compared with other Jamaicamides such as Jamaicamide B and C, Jamaicamide A has the least active fish toxin (sublethal toxicity at 10 ppm after 90 min), and neither showed significant brine shrimp toxicity. [2]

Biosynthesis

Biosynthetic precursors of jamaicamide A Biosynthetic Precursors of Jamaicamide A.png
Biosynthetic precursors of jamaicamide A

It has been predicted that jamaicamide A's biosynthetic pathways are from a hybrid polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS) assembly units. Jamaicamide A is a popetides with a colinear arrangement with a chemical structure that suggests it is derived from various polyketides (9 acetate units), amino acids (L-Ala and β-Ala), and methionine-derived methyl groups. Nevertheless, it has distinctive molecular features like the terminal alkynyl bromide, vinyl chloride, and pyrrolinone ring. The biosynthetic origins and mechanism of formation of the pyrrolinone ring system are unknown. [2]

Proposed biosynthesis of jamaicamide A adapted from Edwards, D. J. et al. 2004 Proposed biosynthesis of Jamaicamides A.png
Proposed biosynthesis of jamaicamide A adapted from Edwards, D. J. et al. 2004

The first proposed biosynthesis of jamaicamide A published in 2004. [2] Another proposed biosynthesis of jamaicamide A was published in 2006. [3]

Related Research Articles

<span class="mw-page-title-main">Bleomycin</span> Glycopeptide antibiotic used to treat various cancers

Bleomycin is a medication used to treat cancer. This includes Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, ovarian cancer, and cervical cancer among others. Typically used with other cancer medications, it can be given intravenously, by injection into a muscle or under the skin. It may also be administered inside the chest to help prevent the recurrence of a pleural effusion due to cancer; however talc is better for this.

<i>Moorea producens</i> Species of bacterium

Moorea producens is a species of filamentous cyanobacteria in the genus Moorea, including tropical marine strains formerly classified as Lyngbya majuscula due to morphological resemblance but separated based on genetic evidence. Moorea producens grows on seagrass and is one of the causes of the human skin irritation seaweed dermatitis. It is known as fireweed in Australia and stinging limu in Hawaii.

<span class="mw-page-title-main">Lyngbyatoxin-a</span> Chemical compound

Lyngbyatoxin-a is a cyanotoxin produced by certain cyanobacteria species, most notably Moorea producens. It is produced as defense mechanism to ward off any would-be predators of the bacterium, being a potent blister agent as well as carcinogen. Low concentrations cause a common skin condition known as seaweed dermatitis.

<span class="mw-page-title-main">Codinaeopsin</span> Chemical compound

Codinaeopsin is an antimalarial isolated from a fungal isolate found in white yemeri trees (Vochysia guatemalensis) in Costa Rica. It is reported to have bioactivity against Plasmodium falciparum with an IC50 = 2.3 μg/mL (4.7 μM). Pure codinaeopsin was reported to be isolated with a total yield of 18 mg/mL from cultured fungus. The biosynthesis of codinaeopsin involves a polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS) hybrid.

<span class="mw-page-title-main">Scytonemin</span> Chemical compound

Scytonemin is a secondary metabolite and an extracellular matrix (sheath) pigment synthesized by many strains of cyanobacteria, including Nostoc, Scytonema, Calothrix, Lyngbya, Rivularia, Chlorogloeopsis, and Hyella. Scytonemin-synthesizing cyanobacteria often inhabit highly insolated terrestrial, freshwater and coastal environments such as deserts, semideserts, rocks, cliffs, marine intertidal flats, and hot springs.

<span class="mw-page-title-main">Apratoxin A</span> Chemical compound

Apratoxin A - is a cyanobacterial secondary metabolite, known as a potent cytotoxic marine natural product. It is a derivative of the Apratoxin family of cytotoxins. The mixed peptide-polyketide natural product comes from a polyketide synthase/non-ribosomal peptide synthase pathway (PKS/NRPS). This cytotoxin is known for inducing G1-phase cell cycle arrest and apoptosis. This natural product's activity has made it a popular target for developing anticancer derivatives.

<i>Lyngbya majuscula</i> Species of bacterium

Lyngbya majuscula is a species of filamentous cyanobacteria in the genus Lyngbya. It is named after the Dane Hans Christian Lyngbye.

<span class="mw-page-title-main">Anthracimycin</span> Polyketide

Anthracimycin is a polyketide antibiotic discovered in 2013. Anthracimycin is derived from marine actinobacteria. In preliminary laboratory research, it has shown activity against Bacillus anthracis, the bacteria that causes anthrax, and against methicillin-resistant Staphylococcus aureus (MRSA).

<span class="mw-page-title-main">Hectochlorin</span> Chemical compound

Hectochlorin is a lipopeptide that exhibits potent antifungal activity against C. albicans and a number of plants pathogens, as well as inhibiting growth of human cell lines by hyperpolymerization of actin. It was originally isolated from the filamentous cyanobacterium Moorea producens JHB, collected from Hector Bay, Jamaica, 1996, which is a strain also known for being the producer of other two potent biomolecules named Jamaicamide A and Cryptomaldamide. Due to its activity against plants pathogens, synthetic efforts elucidated the compound’s total synthesis in 2002. Moorea species are normally the main component of the dietary of some sea hares, which concentrate the cyanobacterial metabolites as a mechanism of defense from predators. Therefore, in 2005, hectochlorin was re-isolated from the Thai sea hare Bursatella leachii, along with a new analogue, deacetylhectochlorin. Another reisolation of hectochlorin was reported in 2013, from another Moorea producens strain (RS05), isolated from the Red Sea, surprising in a non-tropical environment, as opposed to the other Moorea strains isolated before. The predicted biosynthesis of hectochlorin was published in 2007 and consists in a hybrid NRPS-PKS, with a hexanoic acid as start unit that becomes halogenated twice in the position 5, producing fairly rare gem-dichloro group, that along with two 2,3-dihydroxyisovaleric acid (DHIV) units compose a very interesting bioactive molecule.

<span class="mw-page-title-main">Pseurotin A</span> Chemical compound

Pseurotin A is a secondary metabolite of Aspergillus.

Curacin A is a hybrid polyketide synthase (PKS)/nonribosomal peptide synthase (NRPS) derived natural product produced isolated from the cyanobacterium Lyngbya majuscula. Curacin A belongs to a family of natural products including jamaicamide, mupirocin, and pederin that have an unusual terminal alkene. Additionally, Curacin A contains a notable thiazoline ring and a unique cyclopropyl moiety, which is essential to the compound's biological activity. Curacin A has been characterized as potent antiproliferative cytotoxic compound with notable anticancer activity for several cancer lines including renal, colon, and breast cancer. Curacin A has been shown to interact with colchicine binding sites on tubulin, which inhibits microtubule polymerization, an essential process for cell division and proliferation.

<span class="mw-page-title-main">Antillatoxin</span> Chemical compound

Antillatoxin (ATX) is a potent lipopeptide neurotoxin produced by the marine cyanobacterium Lyngbya majuscula. ATX activates voltage-gated sodium channels, which can cause cell depolarisation, NMDA-receptor overactivity, excess calcium influx and neuronal necrosis.

Kalkitoxin, a toxin derived from the cyanobacterium Lyngbya majuscula, induces NMDA receptor mediated neuronal necrosis, blocks voltage-dependent sodium channels, and induces cellular hypoxia by inhibiting the electron transport chain (ETC) complex 1.

<span class="mw-page-title-main">C-1027</span> Chemical compound

C-1027 or lidamycin is an antitumor antibiotic consisting of a complex of an enediyne chromophore and an apoprotein. It shows antibiotic activity against most Gram-positive bacteria. It is one of the most potent cytotoxic molecules known, due to its induction of a higher ratio of DNA double-strand breaks than single-strand breaks.

<span class="mw-page-title-main">Pyoluteorin</span> Chemical compound

Pyoluteorin is a natural antibiotic that is biosynthesized from a hybrid nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) pathway. Pyoluteorin was first isolated in the 1950s from Pseudomonas aeruginosa strains T359 and IFO 3455 and was found to be toxic against oomycetes, bacteria, fungi, and against certain plants. Pyoluteorin is most notable for its toxicity against the oomycete Pythium ultimum, which is a plant pathogen that causes a global loss in agriculture. Currently, pyoluteorin derivatives are being studied as an Mcl-1 antagonist in order to target cancers that have elevated Mcl-1 levels.

<span class="mw-page-title-main">Swinholide</span> Chemical compound

Swinholides are dimeric 42 carbon-ring polyketides that exhibit a 2-fold axis of symmetry. Found mostly in the marine sponge Theonella, swinholides encompass cytotoxic and antifungal activities via disruption of the actin skeleton. Swinholides were first described in 1985 and the structure and stereochemistry were updated in 1989 and 1990, respectively. Thirteen swinholides have been described in the literature, including close structural compounds such as misakinolides/bistheonellides, ankaraholides, and hurgholide A It is suspected that symbiotic microbes that inhabit the sponges rather than the sponges themselves produce swinholides since the highest concentration of swinholides are found in the unicellular bacterial fraction of sponges and not in the sponge fraction or cyanobacteria fraction that also inhabit the sponges.

<span class="mw-page-title-main">Annimycin</span> Polyenoic acid amide natural product produced by Streptomyces calvus

Annimycin (4-(Z)-annimycin) is a polyenoic acid amide natural product produced by Streptomyces calvus. Annimycin inhibits the sporulation of several actinobacterial genera.

<span class="mw-page-title-main">Hoiamides</span> Chemical compound

The hoiamides are a class of small molecules recently characterized from isolations of secondary metabolites of cyanobacteria that feature a triheterocyclic system. Hoiamide A and B are cyclic while hoiamide C and D are linear. Hoiamide A and B demonstrate neurotoxicity by acting on mammalian voltage gated sodium channels, while hoiamide D shows inhibition of the p53/MDM2 complex. The hoiamides are promising therapeutic targets, making their total synthesis an attractive feat.

<span class="mw-page-title-main">Aureothin</span> Chemical compound

Aureothin is a natural product of a cytotoxic shikimate-polyketide antibiotic with the molecular formula C22H23NO6. Aureothin is produced by the bacterium Streptomyces thioluteus that illustrates antitumor, antifungal, and insecticidal activities and the new aureothin derivatives can be antifungal and antiproliferative. In addition, aureothin, a nitro compound from Streptomyces thioluteus, was indicated to have pesticidal activity against the bean weevil by interfering with mitochondrial respiratory complex II.

<span class="mw-page-title-main">Lyngbyastatins</span> Chemical compound

Lyngbyastatins 1 and 3 are cytotoxic cyclic depsipeptides that possess antiproliferative activity against human cancer cell lines. These compounds, first isolated from the extract of a Lyngbya majuscula/Schizothrix calcicola assemblage and from L. majuscula Harvey ex Gomont (Oscillatoriaceae) strains, respectively, target the actin cytoskeleton of eukaryotic cells.

References

  1. Ma, Liang; Zhang, Qingbo; Yang, Chunfang; Zhu, Yiguang; Zhang, Liping; Wang, Lijuan; Liu, Zhiwen; Zhang, Guangtao; Zhang, Changsheng (2020). "1.06 - Assembly Line and Post-PKS Modifications in the Biosynthesis of Marine Polyketide Natural Products". Comprehensive Natural Products III: 139–197. doi:10.1016/B978-0-12-409547-2.14711-0. ISBN   9780081026915. S2CID   213115096 . Retrieved 20 May 2023.
  2. 1 2 3 4 5 Edwards, Daniel J.; Marquez, Brian L.; Nogle, Lisa M.; McPhail, Kerry; Goeger, Douglas E.; Roberts, Mary Ann; Gerwick, William H. (2004). "Structure and Biosynthesis of the Jamaicamides, New Mixed Polyketide-Peptide Neurotoxins from the Marine Cyanobacterium Lyngbya majuscula". Chemistry & Biology. 11 (6): 817–833. doi: 10.1016/j.chembiol.2004.03.030 . PMID   15217615.
  3. Vaillancourt, Frédéric H.; Yeh, Ellen; Vosburg, David A.; Garneau-Tsodikova, Sylvie; Walsh, Christopher T. (2006). "Nature's Inventory of Halogenation Catalysts: Oxidative Strategies Predominate". Chemical Reviews. 106 (8): 3364–3378. doi:10.1021/cr050313i. PMID   16895332.